Corporate News
Minerva Neurosciences (NERV)
- Trading session (Friday, 23 Feb 2026, 07:29 AM CET): Shares closed up 0.42 %.
- Current price: USD 2.40 on major exchanges.
- Shares outstanding: 47.7 million.
- Market capitalization: USD 114.1 million.
- Volume (last 24 h): USD 290.6 k traded.
- Month‑to‑date change: ‑31.23 % decline since the previous month‑end.
- Technical indicators:
- 200‑day simple moving average: USD 4.97.
- 52‑week high: USD 8.80 (16 Mar 2026).
- 52‑week low: USD 2.24 (19 Oct 2026).
Related Stock Performance (Last 24 h)
| Symbol | Company | % Change | Current Price | Market Cap (USD million) |
|---|---|---|---|---|
| FEAM | 5e Advanced Materials | +5.06 % | USD 2.31 | 134 |
| KRRO | Korro Bio | –1.59 % | USD 12.05 | 136.8 |
| FGBI | First Guaranty Bancshares | +2.68 % | USD 8.44 | 136 |
| OTLK | Outlook Therapeutics | +0.53 % | USD 0.56 | 136.7 |
| ANTX | An2 Therapeutics | +1.12 % | USD 3.64 | 135.9 |
Company Overview
Minerva Neurosciences, Inc. is a clinical‑stage biopharmaceutical company headquartered in Waltham, Massachusetts, USA. The company focuses on developing therapies for central nervous system (CNS) and neuropsychiatric disorders. It operates within the Health Care sector of the biotechnology industry.